Skip to content

Jason B. Luoma

33 papers in the library · 729 citations · publishing 2011-2026

Papers

Sort Most recent Most cited

Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca

Journal of Psychopharmacology March 1, 2022 Gabrielle Agin-Liebes, Richard J. Zeifman, Jason B. Luoma et al. 51 citations

Background: Evidence suggests that psychedelic-assisted therapy carries transdiagnostic efficacy in the treatment of mental health conditions characterized by low mood and the use of avoidance coping strategies. Aims: While preliminary evidence suggests that psychological flexibility and emotion regulation processes play an important role within psychedelic therapy, this prospective study...

MDMA-Assisted Therapy as a Means to Alter Affective, Cognitive, Behavioral, and Neurological Systems Underlying Social Dysfunction in Social Anxiety Disorder

Frontiers in Psychiatry September 27, 2021 Jason B. Luoma, M. Kati Lear 11 citations

Social anxiety disorder (SAD) is a prevalent and often debilitating psychiatric disorder that can assume a chronic course even when treated. Despite the identification of evidence-based pharmacological and behavioral treatments for SAD, much room for improved outcomes exists and 3,4-methylenedioxymethamphetamine (MDMA) has been proposed as a promising adjunctive treatment to psychological...

Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States

Journal of Psychoactive Drugs September 1, 2021 Alan K. Davis, Gabrielle Agin-Liebes, Megan España et al. 103 citations

Psychologists are a vital component of mental health treatment and their perceptions of psychedelic-assisted therapy are critical for future implementation. This cross-sectional quasi-experimental electronic survey study explored the attitudes about psychedelics used in treatment among 366 clinical psychologists in the United States. Participants expressed cautiously favorable attitudes toward...

Ethical and legal issues in psychedelic harm reduction and integration therapy

Harm Reduction Journal April 11, 2021 Brian Pilecki, Jason B. Luoma, Geoff J. Bathje et al. 135 citations

Abstract Psychedelic-assisted therapy may represent an upcoming paradigm shift in the treatment of mental health problems as recent clinical trials have demonstrated strong evidence of their therapeutic benefits. While psychedelics are currently prohibited substances in most countries, the growing popularity of their therapeutic potential is leading many people to use psychedelics on their own...

DOI: 10.1186/s12954-021-00489-1 (opens in new tab) Full text (opens in new tab) Psychedelic-assisted therapy Psychedelics Psychedelic integration Psychedelic harm reduction +2

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

Journal of Psychoactive Drugs June 12, 2020 Jason B. Luoma, Christina Chwyl, Geoff J. Bathje et al. 206 citations

After a two-decade hiatus in which research on psychedelics was essentially halted, placebo-controlled clinical trials of psychedelic-assisted therapy for mental health conditions have begun to be published. We identified nine randomized, placebo-controlled clinical trials of psychedelic-assisted therapy published since 1994. Studies examined psilocybin, LSD (lysergic acid diethylamide),...

Burnout among the addiction counseling workforce: the differential roles of mindfulness and values-based processes and work-site factors.

Journal of Substance Abuse Treatment January 22, 2011 Roger Vilardaga, Jason B. Luoma, Steven C Hayes et al.

Although work-site factors have been shown to be a consistent predictor of burnout, the importance of mindfulness and values-based processes among addiction counselors has been little examined. In this study, we explored how strongly experiential avoidance, cognitive fusion, and values commitment related to burnout after controlling for well-established work-site factors (job control, coworker...

DOI: 10.1016/j.jsat.2010.11.015 (opens in new tab) Full text (opens in new tab) Humans Substance-related disorders Regression analysis Cross-sectional studies +8

Utilizing In Vivo and Imaginal Exposure in the Context of MDMA-Assisted Therapy for Social Anxiety Disorder: A Case Report

Jason B. Luoma, M. Kati Lear, Kyong Yi et al. preprint

This case report describes the application of in vivo and imaginal exposure techniqueswithin MDMA-assisted therapy (MDMA-AT) for social anxiety disorder (SAD). The treatment,conducted as part of a randomized controlled trial, consisted of three non-drug preparationsessions, two drug sessions, and six non-drug integration sessions. Exposure interventionsincluded imaginal exposure to...

When Therapy Falls Short: A Qualitative Study of Psychotherapy After Challenging Psychedelic Experiences

Guy Simon, Nir Tadmor, Jules Evans et al. preprint

Abstract Background Psychedelic substances are increasingly used outside clinical trials, yet individuals seeking support after challenging experiences often report that available services are inadequate or misaligned with their needs. While prior research documents both beneficial and adverse outcomes of naturalistic use, less is known about how such experiences are received and interpreted...